Adult Stem Cell Research Breakthrough Produces Insulin for Diabetics

Not only that, but it delivers insulin far more effectively than one can do with embryonic stem cells.

The reason: Embryonic-stem-derived Islet-of-Langerhans cells do not conform to any known tissue type--and therefore any patient into whom they were transplanted would reject them. Not so islet-of-Langerhans cell populations derived from umbilical cord-blood stem cells. They deliver insulin far more reliably, and on cue.

This is not the first time that researchers using adult stem cells have produced reliable treatments, far easier to deliver than anything that embryonic stem cells can produce, and without the malignant tumor risk that embryonic stem cells carry. This should be a no-brainer. Unhappily, good healing plays second fiddle to the culture of death in some doctors' minds.